openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

News

Discover

Get above the noise

Log in for answers tailored to you — saved chats, your topics, and the full IJR suite.

IJR.ai — Intelligence belongs to everyone

|NewsJournalsTopicBPC-157

Topic

BPC-157

2 members

Feed News Media Community Map About

2 memberscoverage spread: L0/C100/R0

Comments

Ask this entity anything:

☺

Free account · your comment posts right after signup

Photo: the United States’ — Wikimedia Commons / Wikimedia Commons
FDA panel backs BPC-157 access, Hims shares surge
An FDA advisory panel recommended adding BPC-157 to the list eligible for pharmacy compounding, a move investors interpreted as a boost to Hims & Hers' telehealth and peptide offerings, with the stock jumping about 10–11% across reports. The company, valued around $8.1 billion, has faced insider selling in the past quarter, and regulators’ signaling comes as it positions itself in a growing peptide therapy market.
9 sources

Facts from Wikidata (CC0).

Gastric pentadecapeptide BPC-157 is a synthetic fifteen amino acid oligopeptide derived from a protein found in human gastric juice. BPC-157 has been studied primarily in laboratory animals. BPC-157 is not approved by any drug regulatory agency for human use, and there is limited data regarding its effectiveness on humans.

Read the full article →

Not who you're looking for? Others named BPC-157: chemical compound